We are pleased to invite you to participate in the Fourth International Mammalian Synthetic Biology Workshop (mSBW 4.0) (Download flyer). This workshop will explore the latest trends and advances in the field, including recent foundational accomplishments and applications in addressing challenges to human health and beyond.  This one-and-a-half day meeting brings together world’s leading researchers in synthetic biology, mammalian and cellular biology, and bioengineering from academic as well as industry partners. Our scientific program will include topics in many applications of Genome Engineering & Epigenome Biology, Systems & Genetic Circuits, Developmental & Regenerative Biology, Therapeutic Delivery Systems, and a panel on Synbio Regulatory: “Moving Synthetic Biology to Clinic”

We are also soliciting your contributions as SHORT TALKS and/or POSTERS  as a means to disseminate the most up-to-date research and commercial applications which complement the presentations from the leaders in these fields.  Submit your Abstract by March 31st.

–Please join us as we build the foundation for this exciting and promising new field

mSBW 4.0 will be held at Boston University
on May 6-7, 2017 at CILSE

Featured plenary speakers:

Dr. Josh Fidlerfidler
Distinguished Chair in Cell Biology, and Professor, Department of Cancer Biology, University of Texas MD Anderson Cancer Center (UTMDACC)
A pioneer in the field of cancer metastasis, Dr. Fidler has devoted his research to understanding the nature of primary tumors and their ability to promote the establishment of secondary tumors. One of Dr. Fidler’s most important findings was that tumors are composed of heterogeneous cell populations. He further concluded that within these populations exist specific cell types with metastatic potential. Such findings have suggested that cancer therapies should be geared toward eliminating these small subsets of cells, thereby confining a tumor within its primary organ site.

Paula HammondDr. Paula T. Hammond
David H. Koch Professor in Engineering, Head of the Department of Chemical Engineering, Massachusetts Institute of Technology
Professor Hammond is is a member of MIT’s Koch Institute for Integrative Cancer Research, the MIT Energy Initiative, and a founding member of the MIT Institute for Soldier Nanotechnology. Her laboratory focuses on the molecular design and synthesis of self-assembling polymeric systems for a range of electro-optical, electro-mechanical and biological applications. In cancer research, Hammond’s work focuses on the generation of polymer-based films and nanoparticles for drug delivery. She was recently named the new head of the Department of Chemical Engineering at MIT, the first woman and the first person of color appointed to the post.


**View the previous workshop program, speakers, and booklet**

Related conferences:

We thank our sponsors:

Wyss_logo cthealthlogo BU-logo